BDX logo

BDX

Becton Dickinson and Company

$155.46
-$1.63(-1.04%)
63
Overall
95
Value
50
Tech
44
Quality
How is this score calculated?
Market Cap
$53.26B
Volume
2.53M
52W Range
$153.18 - $213.08
Target Price
$190.18

Latest News for BDX

Becton Dickinson announces planned interventional segment leadership transition
TipRanks Auto-Generated Newsdesk2 hours agoApr 09, 2026

The latest announcement is out from Becton Dickinson ( ($BDX) ). Becton, Dickinson and Company announced that Richard E. Byrd, executive vice presi......

Analysts’ Opinions Are Mixed on These Healthcare Stocks: DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX)
Christine Brown15 hours agoApr 09, 2026

Analysts have been eager to weigh in on the Healthcare sector with new ratings on DaVita (DVA), BridgeBio Pharma (BBIO) and Becton Dickinson (BDX).......

3 Best Dividend Aristocrat Stocks to Buy Now, 04/02/2026
Solomon Oladipupo7 days agoApr 02, 2026

Dividend aristocrats are S&P 500 companies that have raised their shareholder payouts every year for at least 25 years. The article uses the TipRan......

BCAL seeks Medicare backing for Avantect pancreatic cancer blood test
TipRanks Australian Auto-Generated Newsdesk10 days agoMar 31, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) just unveiled an announcement. BCAL Diagnostics has lodged an application with the Medical Services Advisory......

Abingdon Health Wins £4.8m U.S. Contracts for Multiplex Lateral Flow Systems
TipRanks UK Auto-Generated Newsdesk11 days agoMar 30, 2026

An update from Abingdon Health PLC ( ($GB:ABDX) ) is now available. Abingdon Health has secured approximately £4.8m of contracts from a US-based cu......

BCAL speeds national rollout of Avantect cancer blood tests
TipRanks Australian Auto-Generated Newsdesk15 days agoMar 25, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) has provided an update. BCAL Diagnostics has expanded national access to its Avantect pancreatic and ovarian......

BCAL speeds national rollout of Avantect cancer blood tests
TipRanks Australian Auto-Generated Newsdesk15 days agoMar 25, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) has provided an update. BCAL Diagnostics has expanded national access to its Avantect pancreatic and ovarian......

BCAL Director Jayne Shaw Increases Shareholding via On‑Market Purchase
TipRanks Australian Auto-Generated Newsdesk21 days agoMar 20, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) has issued an announcement. BCAL Diagnostics has disclosed a change in the interests of director Jayne Shaw,......

BCAL Director Jayne Shaw Increases Shareholding Via On-Market Purchase
TipRanks Australian Auto-Generated Newsdesk22 days agoMar 19, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) has issued an update. BCAL Diagnostics has reported a change in the interests of director Jayne Shaw, who ha......

BCAL director Jayne Shaw boosts stake with on-market share purchase
TipRanks Australian Auto-Generated Newsdesk24 days agoMar 17, 2026

BCAL Diagnostics Limited ( ($AU:BDX) ) has provided an announcement. BCAL Diagnostics director Jayne Shaw has increased her shareholding in the com......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.

ABCD
1SymbolPriceChangeVol
2BDX$155.46-1.0%2.53M
3
4
5
6

Get Becton Dickinson and Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.